Danilo Tófoli

Danilo Tófoli

Auto-generated profile, based on publicly available information

Danilo Tófoli

Institute of Chemistry, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
EFElaine de S. Fernandes
Elaine de S. Fernandes
FRFátima A. Rodrigues
Fátima A. Rodrigues
DTDanilo Tófoli
Danilo Tófoli
PIPaulo M. Imamura
Paulo M. Imamura
JCJoão E. de Carvalho
João E. de Carvalho
RSRogério C.L. Silva
Rogério C.L. Silva
The cytotoxicity of a hexanic fraction produced from the ethanolic crude extract, obtained from Jatropha ribifolia (Pohl) Baill, Euphorbiaceae, roots was evaluated against ten human cancer cell lines (MCF-7, NCI-ADR/RES, OVCAR-3, PC-3, HT-29, NCI-H460, 786-O, UACC-62, K-562, U251) compared with doxorrubicine as positive control. Compounds jatrophone and cyperenoic acid were isolated from the hexanic extract and characterized by spectroscopic techniques (NMR of 1H, 13C and IR). The in vitro antiproliferative activity of jatrophone showed selectivity in a concentration dependent way with Total Inhibition growth of: glioma 0.57μg mL−1 (U251), breast cancer 9.2μg mL−1 (MCF-7), adriamycinresistant ovarian cancer 0.96μg mL−1 (NCI-ADR/RES), kidney 4.2μg mL−1 (786-0), prostate cancer 8.4μg mL−1 (PC-3), colon cancer 16.1μg mL−1 (HT29) and leukemia 0.21μg mL−1 (K-562)

1 January 2014 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Open access
CSCelia E. L. da Silva
Celia E. L. da Silva
SMSandro Minguzzi
Sandro Minguzzi
RSRogério C. L. da Silva
Rogério C. L. da Silva
MMMaria F. C. Matos
Maria F. C. Matos
DTDanilo Tofoli
Danilo Tofoli
ESEuclesio Simionatto
Euclesio Simionatto
The essential oil of roots of Jatropha ribifolia, obtained by hydrodistillation, was characterized in terms of its chemical composition by chromatographic method with flame ionization detection (GC-FID) and gas chromatography coupled to electron ionization mass spectrometry (GC-MS). The analyses and identification pointed by mass fragmentation pattern and retention index revealed the presence of 49 compounds, representing 91.4% of the total oil, with 39.5% of monoterpenes, 43.0% of sesquiterpenes and 8.5% of phenylpropanoids. The major compounds of the oil were β-pinene (9.2%), isoeugenol methyl ether (8.5%), vatirenene (8.4%), α-gurjunene (7.0%), endo-8-hydroxy-cycloisolongifolene (6.6%), α-pinene (6.4%) and p-menth-1-en-8-ol (5.2%). The fractionation by preparative thin layer chromatography (TLC) allowed obtaining five fractions (F1-F5) with different compound contents from the original oil. Some essential oil components showed a significant increase in their levels after fractionation, as borneol (17.9%, F1), 3-thujopsanone (19.1%, F4), isoeugenol methylether (21.2%, F2), 8-oxo-9H-cycloisolongifolene (21.4%, F4), 8-cis-5(1H)-azulenone,2,4,6,7,8,8a-hexahydro-3,8-dimethyl-4-(1-methylethylidene) (23.1%, F4) e endo-8-hydroxy-cycloisolongifolene (38.6%, F2). These fractions and oil were tested in vitro against nine human cancer cell lines by sulforhodamine B assay. The Jatropha oil was more effective in inhibiting the growth of cells NCI-H460 (drug resistant ovarian; GI50 6.2 μg mL-1) and OVCAR-3 (ovarian; GI50 8.0 μg mL-1). The cancer cells line PC-3 (prostate) was more sensitive to the effects of the fractions showing significant values of GI50 such as for fraction F1, F2 and F4 (< 0.25 μg mL-1). In general the antiproliferative activity of the fractions was more pronounced than that of crude oil

1 January 2016 in Planta Medica Letters
Verified
Journal Article
Open access
PDF file
DTDanilo Tófoli
Danilo Tófoli
LMLaura Alves Verão Martins
Laura Alves Verão Martins
MMMaria de Fátima Cepa Matos
Maria de Fátima Cepa Matos
WGWalmir Silva Garcez
Walmir Silva Garcez
FGFernanda Rodrigues Garcez
Fernanda Rodrigues Garcez
Bioassay-guided fractionation of the ethanol extract from the leaves of Mezilaurus crassiramea, which was toxic to Artemia salina larvae, afforded 3′-acetylrubrenolide (1), 2′,3′-diacetylrubrenolide (2), and rubrenolide (3) from the active dichloromethane soluble fraction. Compound 1 is new, while 2 and 3 are first reported from a natural source and in the Mezilaurus genus, respectively. Compound 3 showed significant cytotoxicity against UACC-62, MCF-7, HT-29, and PC-3 human cancer cell lines, with GI50 values ranging from 3.3 to 9.9 µg/mL, while 1 and 2 exhibited marginal activities against at least five of the six investigated cell lines. The structures of 1–3 were established on the basis of 1D- and 2D-nuclear magnetic resonance analyses, high-resolution electrospray ionization mass spectrometry data and specific optical rotation values.

3 March 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LHLanna M. Heemann
Lanna M. Heemann
KSKamylla Fernanda Souza de Souza
Kamylla Fernanda Souza de Souza
DTDanilo Tófoli
Danilo Tófoli
KFKelly J. Filippin
Kelly J. Filippin
WGWalmir Garcez
Walmir Garcez
RPRenata T. Perdomo
Renata T. Perdomo
Majoranolide, a butanolide isolated from the nonpolar fraction of an ethanol extract of Mezilaurus crassiramea (Lauraceae) fruits, is being reported for the first time in this genus and the third time in plants. Structurally identified from 1D and 2D NMR and HRESIMS data, majoranolide proved cytotoxic against cancer cells—MCF-7 and MDA-MB-231 (breast), HT-29 (colon), PC-3 (prostate), 786-0 (renal), and HL-60 (leukemia)—inhibiting growth in HL-60 cells (GI50 = 0.21 μM) and exhibiting higher selectivity for this line than for nonneoplastic NIH/3T3 murine fibroblasts. Effects on the cell cycle, caspase-3 activation, and plasma membrane integrity were evaluated by flow cytometry. Expression of genes related to apoptotic pathways (BAX, BCL2, BIRC5, and CASP8) was investigated using RT-qPCR. At 50 μM, majoranolide induced cell cycle arrest at G1 in 24 h increased the sub-G1 population in 48 h and increased caspase-3 activation in a time-dependent manner. The compound upregulated BAX and CASP8 transcription (proapoptotic genes) and downregulated BIRC5 (antiapoptotic). Loss of plasma membrane integrity in 30% of cells occurred at 48 h, but not at 24 h, characterizing gradual, programmed death. The results suggest that majoranolide cytotoxicity involves apoptosis induction in HL-60 cells, although other mechanisms may contribute to this cell death.

28 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JAJúlio Menta de Almeida
Júlio Menta de Almeida
FNFelipe Oliveira Nunes
Felipe Oliveira Nunes
LCLígia Fernanda Ceole
Lígia Fernanda Ceole
TKTabata D’mAiella Freitas Klimeck
Tabata D’mAiella Freitas Klimeck
LCLetícia Alves da Cruz
Letícia Alves da Cruz
AFAlda Maria Teixeira Ferreira
Alda Maria Teixeira Ferreira
Butanolides have shown a variety of biological effects including anti-inflammatory, antibacterial, and antiprotozoal effects against certain strains of Trypanosoma cruzi. Considering the lack of an effective drug to treat T. cruzi infections and the prominent results obtained in literature with this class of lactones, we investigated the anti-T. cruzi activity of five butanolides isolated from two species of Lauraceae, Aiouea trinervis and Mezilaurus crassiramea. Initially, the activity of these compounds was evaluated on epimastigote forms of the parasite, after a treatment period of 4 h, followed by testing on amastigotes, trypomastigotes, and mammalian cells. Next, the synergistic effect of active butanolides against amastigotes was evaluated. Further, metacyclogenesis inhibition and infectivity assays were performed for the most active compound, followed by ultrastructural analysis of the treated amastigotes and trypomastigotes. Among the five butanolides studied, majoranolide and isoobtusilactone A were active against all forms of the parasite, with good selectivity indexes in Vero cells. Both butanolides were more active than the control drug against trypomastigote and epimastigote forms and also had a synergic effect on amastigotes. The most active compound, isoobtusilactone A, which showed activity against all tested strains inhibited metacyclogenesis and infection of new host cells. In addition, ultrastructural analysis revealed that this butanolide caused extensive damage to the mitochondria of both amastigotes and trypomastigotes, resulting in severe morphological changes in the infective forms of the parasite. Altogether, our results highlight the potential of butanolides against the etiologic agent of Chagas disease and the relevance of isoobtusilactone A as a strong anti-T. cruzi drug, affecting different events of the life cycle and all evolutionary forms of parasite after a short period of exposure.

1 February 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
KSKamylla Fernanda Souza de Souza
Kamylla Fernanda Souza de Souza
DTDanilo Tófoli
Danilo Tófoli
IPIndiara Correia Pereira
Indiara Correia Pereira
KFKelly Juliana Filippin
Kelly Juliana Filippin
AGAna Tereza Gomes Guerrero
Ana Tereza Gomes Guerrero
RPRenata Trentin Perdomo
Renata Trentin Perdomo